- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01126320
Frequency of Ventilator Associated Pneumonia (VAP) in Mechanically Ventilated Patients Using the AnapnoGuard System
February 17, 2016 updated by: Hospitech Respiration
Frequency of Ventilator Associated Pneumonia (VAP) in Mechanically Ventilated ICU Patients Using the AnapnoGuard System
Ventilator Associated Pneumonia (VAP) is a common complication experienced by mechanically ventilated patients and within the framework of Respiratory Intensive Care Units.
The AnapnoGuard system, developed by Hospitech Respiration Ltd. is a ventilation guard system that includes a number of unique characteristics.
This study was designed to test the frequency VAP in mechanically ventilated ICU patients using the AnapnoGuard System.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
161
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Haifa, Israel
- Rambam Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- ICU patients;
- Patient was connected to AnapnoGuard system up to six hours from intubation;
- Age - above 18.
Exclusion Criteria:
- Pneumonia;
- Aspiration Pneumonia;
- Chronic or Severe Pneumonia;
- Chronic Obstructive Pulmonary Disease (COPD) requiring permanent home-based antibiotic treatment;
- Interstitial Lung Disease (ILD);
- Post Lung Transplant State;
- Immunosuppression.
- Patients ventilated in prone position
- Patient who was ventilated 3 months prior to being enrolled in the study
- Pregnant women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: AnapnoGuard 100
Respiratory guard system during mechanical ventilation
|
Respiratory guard system during mechanical ventilation with routine mechanical ventilator
|
Active Comparator: Control
routine mechanical ventilator
|
routine mechanical ventilation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
VAP occurence
Time Frame: 2 years
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Adverse events occurence
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yaron Bar Lavi, Dr., Rambam Medical Center, Haifa Israel
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2010
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
December 1, 2015
Study Registration Dates
First Submitted
May 15, 2010
First Submitted That Met QC Criteria
May 18, 2010
First Posted (Estimate)
May 19, 2010
Study Record Updates
Last Update Posted (Estimate)
February 19, 2016
Last Update Submitted That Met QC Criteria
February 17, 2016
Last Verified
February 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HST -AG -02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventilator Associated Pneumonia
-
Hospital Alemão Oswaldo CruzMinistry of Health, BrazilRecruitingHealthcare-Associated Pneumonia | Ventilator-Associated Pneumonia | Healthcare Associated InfectionBrazil
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Cubist Pharmaceuticals LLCCompletedLung Diseases | Healthcare-Associated Pneumonia | Ventilator-Associated Pneumonia
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
University Hospital OlomoucCompletedVentilator-Associated Pneumonia
-
Aydin Adnan Menderes UniversityNot yet recruitingVentilator-Associated PneumoniaTurkey
-
Istanbul Medeniyet UniversityRecruiting
-
University Hospital, ToulouseRecruitingVentilator-associated PneumoniaFrance
-
Erasmus Medical CenterChiesi Farmaceutici S.p.A.CompletedVentilator Associated Pneumonia (VAP)Spain, Netherlands
-
Andrzej Frycz Modrzewski Krakow UniversityCompletedVAP - Ventilator Associated PneumoniaPoland
Clinical Trials on AnapnoGuard 100,
-
Hospitech RespirationCompletedVentilator Associated PneumoniaRomania
-
Hospitech RespirationCompleted
-
Hospitech RespirationCompleted
-
OrthoTrophix, IncCompleted
-
Wageningen UniversityFriesland CampinaUnknownNutrition | Metabolism | Genomics | Postprandial MetabolismNetherlands
-
San Diego State UniversityCompleted
-
Sumitomo Pharma America, Inc.BehaVR LLCCompletedSocial Anxiety Disorder (SAD)United States
-
ShireCompletedAcute Viral ConjunctivitisUnited States, Brazil
-
ExThera Medical CorporationCompletedBacteremia | Bacterial InfectionGermany
-
Yonsei UniversityUnknownRetinal Vascular OcclusionKorea, Republic of